Submitted by Anonymous (not verified) on 24 February 2026 - 16:00
Human medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 5, Status: Authorised